Essilor's Stellest Lenses

Slows the progression of myopia in your child¹

Myopia is becoming increasingly common among children. When it progresses rapidly, it can increase the risk of certain long-term eye complications.

Essilor® Stellest® lenses are specially designed to correct myopia while helping to slow its progression, supporting a child’s visual development during the years when their vision changes the most.

A proven solution for managing myopia

Essilor® Stellest® lenses slow the progression of myopia by an average of 67% compared to standard lenses when worn 12 hours a day, every day.¹

This effectiveness is supported by clinical studies and is based on technology developed specifically to meet the needs of children with myopia and those at high risk of developing myopia.

Clear vision for learning, playing, and exploring

Children use their eyes constantly: at school, while reading, in front of screens, and during sports and recreational activities. Stellest® lenses provide clear vision thanks to a focal zone designed to ensure excellent visual quality every day.

The goal is simple: to allow your child to fully enjoy their activities while benefiting from an age-appropriate myopia management solution.

A technology designed to slow the progression of myopia

Stellest® lenses feature a constellation of 1,021 invisible microlenses embedded in the lens. This exclusive technology creates a defocus signal in front of the retina, helping to slow the elongation of the ey, one of the main factors associated with the progression of myopia.

This innovation makes it possible to:

Stellest® 2.0: The Next Generation of Myopia Control 

Stellest® 2.0 represents the latest evolution of Essilor’s Stellest® platform. Designed based on clinical insights gained from the first generation of Stellest® lenses, it incorporates the new H.A.L.T. MAX technology to offer an even more advanced approach to myopia control in children. With Stellest® 2.0, the growth of the eyes in myopic children was 1.88 times slower than with the previous version.2-4

Thanks to an optimized microlens design, Stellest® 2.0 generates a larger volume of light and a signal that is twice as strong as that of unfocused light, positioned farther in front of the retina. This innovation aims to strengthen the signal to slow the axial elongation of the eye, a factor associated with the progression of myopia.2-4

Like all Stellest® lenses, this new generation offers clear, comfortable vision while seamlessly integrating into children's daily activities.

Why intervene early?

Myopia generally progresses throughout childhood and adolescence. The earlier it is treated, the more likely it is that its progression can be slowed. Stellest lenses are clinically proven to slow the progression of myopia in children as young as six years old.5

Regular follow-up visits with an eye care professional allow you to monitor changes in your child's vision and assess the solutions best suited to their needs.

A solution designed for active children

Designed to be worn all day long, Stellest® lenses easily fit into the daily lives of young wearers. Whether at school, while doing homework, during sports, or on family outings, they offer a solution designed to support a child’s vision today and for years to come.

Find out if Stellest® is right for your child

Your Opto-Réseau professional can assess your child's vision, monitor the progression of their nearsightedness, and determine whether Essilor® Stellest® lenses are a suitable solution for their situation.

Legal Notice
1Essilor® Stellest® lenses slow the progression of myopia by an average of 67% compared to single-vision lenses when worn 12 hours a day, every day. See Essilor’s scientific references for details on the clinical studies.

Legal Notices (Stellest 2.0)

2Essilor® Stellest® 2.0 lenses feature H.A.L.T. MAX (Highly Aspherical Lenslet Target MAX) technology.

3Based on the results of a 12-month prospective, randomized, double-blind, contralateral crossover clinical trial conducted with 50 myopic children in Singapore.

4Clinical results demonstrate a greater reduction in axial length compared to first-generation Essilor® Stellest® lenses.

5Compared to single-vision lenses. Results from a prospective, randomized, double-blind, multicenter clinical trial conducted in the United States among myopic children aged 6 to 12 years at the start of treatment.